Qsemble Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,743	Closed	-$1.24M	–	479
2024 Q3	$1.24M	Buy	+10,743	New	+$1.24M	0.23%	149